E. BAL Et Al. , "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression," Cold Spring Harbor Laboratory , 2022
BAL, E. Et Al. 2022. Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression. Cold Spring Harbor Laboratory .
BAL, E., Yelgen, G., Odabaş, S. P., Metin, A. S., Karakaya, E., Gülden, G., ... Sert, B.(2022). Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression. Cold Spring Harbor Laboratory .
BAL, ENES Et Al. "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression," Cold Spring Harbor Laboratory , 2022
BAL, ENES Et Al. "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression." Cold Spring Harbor Laboratory , 2022
BAL, E. Et Al. (2022) . "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression." Cold Spring Harbor Laboratory .
@article{article, author={ENES BAL Et Al. }, title={Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression}, journal={Cold Spring Harbor Laboratory}, year=2022}